Shi C S, Kehrl J H
B Cell Molecular Immunology Section, Laboratory of Immunoregulation, NIAID, National Institutes of Health, Bethesda, Maryland 20892-1876, USA.
J Biol Chem. 1997 Dec 19;272(51):32102-7. doi: 10.1074/jbc.272.51.32102.
A key step by which tumor necrosis factor (TNF) signals the activation of nuclear factor-kappaB (NF-kappaB) and the stress-activated protein kinase (SAPK, also called c-Jun N-terminal kinase or JNK) is the recruitment to the TNF receptor of TNF receptor-associated factor 2 (TRAF2). However, the subsequent steps in TRAF2-induced SAPK and NF-kappaB activation remain unresolved. Here we report the identification of a TNF-responsive serine/threonine protein kinase termed GCK related (GCKR) that likely signals via mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase kinase 1 (MEKK1) to activate the SAPK pathway. TNF, TRAF2, and ultraviolet (UV) light, which in part uses the TNF receptor signaling pathway, all increased GCKR activity. A TRAF2 mutant, which inhibits both TRAF2-induced NF-kappaB and SAPK activation, blocked TNF-induced GCKR activation. Finally, interference with GCKR expression impeded TRAF2- and TNF-induced SAPK activation but not that of NF-kappaB. This suggests a divergence in the TNF signaling pathway that leads to SAPK and NF-kappaB activation, which is located downstream of TRAF2 but upstream of GCKR.
肿瘤坏死因子(TNF)引发核因子-κB(NF-κB)激活以及应激激活蛋白激酶(SAPK,也称为c-Jun氨基末端激酶或JNK)激活的关键步骤是TNF受体相关因子2(TRAF2)募集到TNF受体。然而,TRAF2诱导的SAPK和NF-κB激活的后续步骤仍未明确。在此我们报告鉴定出一种TNF反应性丝氨酸/苏氨酸蛋白激酶,称为GCK相关激酶(GCKR),它可能通过丝裂原活化蛋白激酶(MAPK)/细胞外信号调节激酶(ERK)激酶激酶1(MEKK1)发出信号来激活SAPK途径。TNF、TRAF2以及部分利用TNF受体信号通路的紫外线(UV)均能增加GCKR活性。一种抑制TRAF2诱导的NF-κB和SAPK激活的TRAF2突变体,能阻断TNF诱导的GCKR激活。最后,干扰GCKR表达会阻碍TRAF2和TNF诱导的SAPK激活,但不会阻碍NF-κB的激活。这表明在TNF信号通路中,导致SAPK和NF-κB激活的过程存在分歧,该分歧位于TRAF2下游但GCKR上游。